Jennifer Saultz: Clinical Trials

1 trial sponsored by Jennifer Saultz, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1

Follow Jennifer Saultz: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Azacitidine, Biospecimen Collection, Bone Marrow Aspiration - Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia
Phase 1RecruitingJennifer Saultz512019-08-162026-09-24

Conditions studied

Leukemia, Myeloid, Acute (1)

Interventions

Azacitidine (1)  ·  Biopsy (1)  ·  Specimen Handling (1)  ·  ruxolitinib (1)  ·  venetoclax (1)

Countries

United States (1)

Top investigators

Jennifer N. Saultz, MD (1)

Results publications

PMID 42007254